ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE: Report from the Medications Working Group of the Lipid Research Clinics Program
- 21 July 1979
- journal article
- Published by Elsevier in The Lancet
- Vol. 314 (8134) , 111-115
- https://doi.org/10.1016/s0140-6736(79)90001-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- ALTERED PLASMA-LIPIDS ASSOCIATED WITH ORAL CONTRACEPTIVE OR ŒSTROGEN CONSUMPTIONThe Lancet, 1977
- Effects of estradiol-17β on cholesterol metabolism in the rat: A study using a deuterium label and mass spectrometrySteroids, 1977
- Gonadal Steroid Effects on Plasma Lipoproteins and Individual PhospholipidsJournal of Clinical Endocrinology & Metabolism, 1972
- The Effects of Oophorectomy and Long-Term Mestranol Therapy on the Serum Lipids of Middle-Aged WomenClinical Science, 1971
- Lipids and the pillLipids, 1971
- SERUM-LIPIDS IN WOMEN ON ORAL CONTRACEPTIVESThe Lancet, 1971
- The Effect of Oral Contraceptives on Serum LipidsFertility and Sterility, 1971
- EFFECTS OF AN ORAL CONTRACEPTIVE AGENT ON PLASMA LIPIDS, PLASMA LIPOPROTEINS, THE INTRAVENOUS FAT TOLERANCE AND THE POST‐HEPARIN LIPOPROTEIN LIPASE ACTIVITYActa Medica Scandinavica, 1971
- FASTING SERUM TRIGLYCERIDE, CHOLESTEROL, AND LIPOPROTEIN LEVELS DURING ORAL-CONTRACEPTIVE THERAPYThe Lancet, 1969
- SERUM LIPIDS AND LIPOPROTEINS DURING LONG-TERM ADMINISTRATION OF AN ORAL CONTRACEPTIVEThe Lancet, 1966